Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin interaction study with chloroquine + proguanil
ISRCTN20647977Phase 4Completed
- Sponsor
- Defence Science and Technology Laboratory
- Start
- Feb 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 4, open-label trial of ciprofloxacin, chloroquine and proguanil in malaria (2 arms), sponsored by Defence Science and Technology Laboratory. Primary endpoints: Pharmacokinetic interaction of ciprofloxacin with chloroquine + proguanil, Pharmacokinetics of chloroquine + proguanil together and 2 more. Started Feb 2008; status: completed.
02
Drugs
ciprofloxacinchloroquineproguanil
03
Conditions
malaria
Beyond the preview
Go deeper on ISRCTN20647977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN20647977.